Active vaccine safety surveillance via a scalable, integrated system in Australian pharmacies
View ORCID ProfileSandra M Salter, Gurkamal Singh, View ORCID ProfileLisa Nissen, View ORCID ProfileKevin Trentino, View ORCID ProfileKevin Murray, Kenneth Lee, Benjamin Kop, Ian Peters, Alan Leeb
doi: https://doi.org/10.1101/2020.12.14.20248212
Sandra M Salter
1School of Allied Health, The University of Western Australia, M315, 35 Stirling Highway, Perth WA 6009. Australia
PhDGurkamal Singh
1School of Allied Health, The University of Western Australia, M315, 35 Stirling Highway, Perth WA 6009. Australia
BScLisa Nissen
2Queensland University of Technology, Level 9, Q Block Room, 911, Brisbane, QLD 4000, Australia
PhDKevin Trentino
3School of Population and Global Health, The University of Western Australia, Perth WA, 6009. Australia
MPHKevin Murray
3School of Population and Global Health, The University of Western Australia, Perth WA, 6009. Australia
PhDKenneth Lee
1School of Allied Health, The University of Western Australia, M315, 35 Stirling Highway, Perth WA 6009. Australia
PhDBenjamin Kop
1School of Allied Health, The University of Western Australia, M315, 35 Stirling Highway, Perth WA 6009. Australia
BScIan Peters
4Illawarra Medical Centre, 29 Illawarra Cres S, Ballajura WA 6066, Australia
BScAlan Leeb
4Illawarra Medical Centre, 29 Illawarra Cres S, Ballajura WA 6066, Australia
FRACGP![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and supplementary material) are available upon reasonable request. Proposals for data should be directed to Sandra Salter via ORCID: https://orcid.org/0000-0002-5840-6797. To gain access to data, users will need to sign a data access agreement. Reuse is permitted under the following conditions: meta-analyses of adverse events following immunisation in pharmacies.
Posted December 16, 2020.
Active vaccine safety surveillance via a scalable, integrated system in Australian pharmacies
Sandra M Salter, Gurkamal Singh, Lisa Nissen, Kevin Trentino, Kevin Murray, Kenneth Lee, Benjamin Kop, Ian Peters, Alan Leeb
medRxiv 2020.12.14.20248212; doi: https://doi.org/10.1101/2020.12.14.20248212
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (212)
- Cardiovascular Medicine (3024)
- Dermatology (256)
- Emergency Medicine (451)
- Epidemiology (12936)
- Forensic Medicine (12)
- Gastroenterology (844)
- Genetic and Genomic Medicine (4737)
- Geriatric Medicine (437)
- Health Economics (744)
- Health Informatics (3003)
- Health Policy (1087)
- Hematology (404)
- HIV/AIDS (950)
- Medical Education (447)
- Medical Ethics (117)
- Nephrology (484)
- Neurology (4521)
- Nursing (241)
- Nutrition (666)
- Oncology (2346)
- Ophthalmology (664)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (510)
- Pediatrics (1224)
- Primary Care Research (513)
- Public and Global Health (7110)
- Radiology and Imaging (1577)
- Respiratory Medicine (936)
- Rheumatology (455)
- Sports Medicine (393)
- Surgery (501)
- Toxicology (63)
- Transplantation (215)
- Urology (187)